MacroGenics Director Kenneth Galbraith Purchases 46,875 Shares (MGNX)
MacroGenics (NASDAQ:MGNX) Director Kenneth Galbraith bought 46,875 shares of MacroGenics stock in a transaction dated Wednesday, October 16th. The shares were purchased at an average price of $16.00 per share, for a total transaction of $750,000.00. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link.
Shares of MacroGenics (NASDAQ:MGNX) traded up 0.97% during mid-day trading on Friday, hitting $25.41. 152,849 shares of the company’s stock traded hands. MacroGenics has a one year low of $23.10 and a one year high of $26.50. The stock has a 50-day moving average of $25.34 and a 200-day moving average of $25.34. The company’s market cap is $49.5 million.
MacroGenics, Inc is a clinical-stage biopharmaceutical company. The Company focuses on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.